omarigliptin
Showing 1 - 9 of 9
Type 2 Diabetes Trial (Omarigliptin, Placebo, Insulin)
Completed
- Type 2 Diabetes Mellitus
- Omarigliptin
- +2 more
- (no location specified)
Aug 15, 2019
Type 2 Diabetes Trial (Omarigliptin, Sitagliptin, Placebo to omarigliptin)
Completed
- Type 2 Diabetes Mellitus
- Omarigliptin
- +3 more
- (no location specified)
Aug 15, 2019
Type 2 Diabetes Trial (Omarigliptin, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Omarigliptin
- Placebo
- (no location specified)
Oct 10, 2018
Type 2 Diabetes Trial (Omarigliptin, Matching to Omarigliptin, Glimepiride)
Completed
- Type 2 Diabetes Mellitus
- Omarigliptin
- +3 more
- (no location specified)
Aug 9, 2018
Type 2 Diabetes Trial (Omarigliptin, Placebo to Omarigliptin, Glimepiride)
Completed
- Type 2 Diabetes Mellitus
- Omarigliptin
- +5 more
- (no location specified)
Aug 8, 2018
Type 2 Diabetes Trial (Omarigliptin, Matching to omarigliptin)
Completed
- Type 2 Diabetes Mellitus
- Omarigliptin
- Matching placebo to omarigliptin
- (no location specified)
Aug 8, 2018
Type 2 Diabetes Trial (Omarigliptin, Matching to omarigliptin, Glimepiride)
Completed
- Type 2 Diabetes Mellitus
- Omarigliptin
- +5 more
- (no location specified)
Aug 9, 2018
Type 2 Diabetes Trial (Omarigliptin, Placebo to omarigliptin, Glipizide)
Completed
- Type 2 Diabetes Mellitus
- Omarigliptin
- +4 more
- (no location specified)
Aug 8, 2018